Published in J Pharmacol Exp Ther on March 01, 1975
Studies on the mechanism of alloxan-diabetes potentiation of carbon tetrachloride-induced liver necrosis. Br J Exp Pathol (1982) 0.75
Chemicals, drugs, and lipid peroxidation. Annu Rev Pharmacol Toxicol (1976) 1.45
Studies on the mechanism of phenobarbital-enhanced sulfobromophthalein disappearance. J Pharmacol Exp Ther (1968) 1.37
Intrahepatic cholestasis induced by drugs and chemicals. Pharmacol Rev (1976) 1.21
Comparison of the biochemical alterations elicited in livers from rats treated with carbon tetrachloride, chloroform, 1,1,2-trichloroethane and 1,1,1-trichloroethane. Biochem Pharmacol (1969) 1.20
The excretion of tritium-labeled chlormadinone acetate, mestranol, norethindrone, and norethynodrel in rats and the enterohepatic circulation of metabolites. Drug Metab Dispos (1974) 1.16
Effect of phenobarbital on the excretion of an exogenous bilirubin load. Biochem Pharmacol (1967) 1.14
Chlorinated hydrocarbon toxicity. Potentiation by isopropyl alcohol and acetone. Arch Environ Health (1974) 1.14
Maximum biliary excretion of bilirubin and sulfobromophthalein during anesthesia-induced alteration of rectal temperature. Proc Soc Exp Biol Med (1967) 1.07
Hepatic subcellular distribution of manganese in manganese and manganese-bilirubin induced cholestasis. Biochem Pharmacol (1985) 1.07
Differences in the potentiation of carbon tetrachloride in rats by ethanol and isopropanol pretreatment. Toxicol Appl Pharmacol (1971) 1.06
Plasma disappearance and biliary excretion of indocyanine green in rats, rabbits, and dogs. Toxicol Appl Pharmacol (1969) 0.98
Relationship of alcohol metabolism to the potentiation of CCl 4 hepatotoxicity induced by aliphatic alcohols. J Pharmacol Exp Ther (1972) 0.97
Relative effects of various chlorinated hydrocarbons on liver and kidney function in mice. Toxicol Appl Pharmacol (1966) 0.97
Functional changes of the biliary tree associated with experimentally induced cholestasis: sulfobromophthalein on manganese-bilirubin combinations. Toxicol Appl Pharmacol (1991) 0.97
The nature of alpha-naphthylisothiocyanate-induced cholestasis. Toxicol Appl Pharmacol (1965) 0.96
Electron microscopy of butylated hydroxytoluene-induced lung damage in mice. Exp Mol Pathol (1977) 0.96
Species variation in metabolism, storage, and excretion of sulfobromophthalein. Am J Physiol (1967) 0.94
A review of the toxicology of the antibiotic MICOTIL 300. Vet Hum Toxicol (1993) 0.94
Relative effects of various chlorinated hydrocarbons on liver and kidney function in dogs. Toxicol Appl Pharmacol (1967) 0.92
Latamoxef-associated hypoprothrombinaemia. Lancet (1983) 0.91
Alteration of the plasma disappearance and biliary excretion patterns of exogenously administered bilirubin by alpha-nephthylisothiocyanate. J Pharmacol Exp Ther (1967) 0.91
Maximal biliary excretion of bilirubin and sulfobromophthalein during various rates of infusion in rats of different weights and strains. Toxicol Appl Pharmacol (1969) 0.90
Effect of simultaneous exposure to toluene and xylene on their respective biological exposure indices in humans. Int Arch Occup Environ Health (1991) 0.89
In vivo oxidation of reduced nicotinamide-adenine dinucleotide phosphate by paraquat and diquat in rat lung. Chem Biol Interact (1977) 0.89
Acute alteration of chloroform-induced hepato- and nephrotoxicity by n-hexane, methyl n-butyl ketone, and 2,5-hexanedione. Toxicol Appl Pharmacol (1980) 0.88
Determination of sulfobromophthalein storage and exertory rate in small animals. J Appl Physiol (1967) 0.88
Studies on the effects on N,N'-dimethylformamide on ethanol disposition and on monoamine oxidase activity in rats. Toxicol Appl Pharmacol (1977) 0.86
Effect of halogenated hydrocarbons on organic ion accumulation by renal cortical slices of rats and mice. Toxicol Appl Pharmacol (1972) 0.85
alpha-Naphthylisothiocyanate (ANIT) hepatotoxicity and irreversible binding to rat liver microsomes. Biochem Pharmacol (1977) 0.84
Mitochondrial injury of pulmonary alveolar epithelial cells in acute paraquat intoxication. Exp Mol Pathol (1985) 0.84
Pathogenesis of lithocholate-induced intrahepatic cholestasis: role of glucuronidation and hydroxylation of lithocholate. Biochim Biophys Acta (1992) 0.83
Potentiation of thioacetamide-induced hepatotoxicity in alloxan- and streptozotocin-diabetic rats. Toxicol Lett (1983) 0.83
Isopropanol and acetone potentiation of carbon tetrachloride-induced hepatotoxicity: single versus repetitive pretreatments in rats. J Toxicol Environ Health (1982) 0.83
Correlation between acetone-potentiated CCl4-induced liver injury and blood concentrations after inhalation or oral administration. Toxicol Appl Pharmacol (1986) 0.82
Acute toxicity of antiepileptic drugs. Epilepsia (1975) 0.82
Monohydroxy bile acid induced cholestasis: role of biotransformation. Drug Metab Rev (1997) 0.81
Quantitative and temporal delineation of various parameters of liver dysfunction due to alpha-naphthylisothiocyanate. Toxicol Appl Pharmacol (1965) 0.81
Potentiation and inhibition of alpha-naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis. J Pharmacol Exp Ther (1965) 0.80
Reduced bile flow after sulfobromophthalein administration in the rat. Proc Soc Exp Biol Med (1970) 0.80
Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N'-nitro-N-nitrosoguanidine cytotoxicity. Toxicol Appl Pharmacol (1996) 0.80
Quantitation of glandular gastric changes in rats given a proton pump inhibitor for 3 months with emphasis on sampling scheme selection. Toxicol Pathol (1998) 0.80
Relationship between the carbon skeleton length of ketonic solvents and potentiation of chloroform-induced hepatotoxicity in rats. Toxicol Lett (1983) 0.80
Functional effects of -naphthylisothiocyanate in various species. Toxicol Appl Pharmacol (1971) 0.80
The effect of SKF 525A on the distribution of carbon tetrachloride in rats. J Pharmacol Exp Ther (1970) 0.80
Catecholamine potentiation of carbon tetrachloride-induced hepatotoxicity in mice. Toxicol Appl Pharmacol (1969) 0.80
Effect of dosing vehicle on the hepatotoxicity of CCl4 and nephrotoxicity of CHCl3 in rats. J Toxicol Environ Health (1997) 0.80
Inability of chrysotile asbestos fibers to modulate the 2-acetylaminofluorene-induced UDS in primary cultures of rat hepatocytes. Mutat Res (1985) 0.80
Disintegration of lung peroxisomes during differentiation of type II cells to type I cells in butylated hydroxytoluene-administered mice. Exp Mol Pathol (1983) 0.79
Modification of haloalkane-induced hepatotoxicity by exogenous ketones and metabolic ketosis. Fed Proc (1980) 0.79
Acetone-induced potentiation of trihalomethane toxicity in male rats. Toxicol Lett (1983) 0.79
Temporal aspects of carbon tetrachloride-induced alteration of sulfobromophthalein excretion and metabolism. Toxicol Appl Pharmacol (1970) 0.79
Biochemical pathology of lung damage produced by chemicals. Fed Proc (1976) 0.79
Protection by 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride against carbon tetrachloride hepatotoxicity. A possible mechanism of action. Biochem Pharmacol (1971) 0.79
Sulfobromophthalein metabolism and excretion in rats with iodomethane-induced depletion of hepatic glutathione. J Pharmacol Exp Ther (1970) 0.79
Extrarenal excretion of drugs and chemicals. Annu Rev Pharmacol (1968) 0.79
Evaluation of health aspects of GRAS food ingredients: lessons learned and questions unanswered. Fed Proc (1977) 0.79
Functional aspects of the cholestatic response induced by -naphthylisothiocyanate in mice and rats. Agents Actions (1969) 0.79
Dose-dependent modification of 1,1-dichloroethylene toxicity by acetone. Toxicol Lett (1983) 0.78
Electron microscopy of a human liver in Weil's disease (leptospirosis icterohaemorrhagica). J Pathol Bacteriol (1966) 0.78
Changes in the number of vesicles and the size of sympathetic nerve terminals following nerve stimulation. Rev Can Biol (1970) 0.78
Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. II. Implication of monooxygenases. J Toxicol Environ Health (1995) 0.78
Effect of norethandrolone, acetohexamide, and Enovid on alpha-naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis. Biochem Pharmacol (1966) 0.78
Potentiation of the hepatotoxic responses to chemicals in alloxan-diabetic rats. Proc Soc Exp Biol Med (1975) 0.78
Biochemical and morphological parameters of taurolithocholate-induced cholestasis. Can J Physiol Pharmacol (1971) 0.78
Toxicity of peptides of Amanita virosa mushrooms in mice. Fundam Appl Toxicol (1985) 0.78
The effect of 6-hydroxydopamine-induced hepatic sympathectomy on the early hyperglycemic response to surgical trauma under anesthesia. J Trauma (1977) 0.77
Hemodynamic effects of CCl4 in the intact liver of the cat. Can J Physiol Pharmacol (1974) 0.77
The nephrotoxicity of single and multiple doses of aliphatic chlorinated hydrocarbon solvents in male mice. Toxicol Appl Pharmacol (1972) 0.77
Methyl isobutyl ketone metabolites and potentiation of the cholestasis induced in rats by a manganese-bilirubin combination or manganese alone. Toxicol Appl Pharmacol (1988) 0.77
Phenobarbitone and biliary excretion. Lancet (1968) 0.77
Phase I and phase II metabolism of lithocholic acid in hepatic acinar zone 3 necrosis. Evaluation in rats by combined radiochromatography and gas-liquid chromatography-mass spectrometry. Biochem Pharmacol (1994) 0.77
Induction of metallothionein gene expression by epidermal growth factor and its inhibition by transforming growth factor-beta and dexamethasone in rat hepatocytes. Hepatology (1995) 0.77
Role of perivenous hepatocytes in taurolithocholate-induced cholestasis in vivo. Toxicol Lett (2000) 0.77
Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. I. Dose-response relationships. J Toxicol Environ Health (1995) 0.77
Effect of aminotriazole on isopropanol- and acetone-induced potentiation of CCl 4 hepatotoxicity. Can J Physiol Pharmacol (1973) 0.77
Measurement of hepatic blood flow by a thermodilution method. J Appl Physiol (1967) 0.77
Tissue concentrations of methyl isobutyl ketone, methyl n-butyl ketone and their metabolites after oral or inhalation exposure. Toxicol Lett (1995) 0.77
Studies on bilirubin production and excretion in mice and rats treated with phenobarbital, chlorpromazine, norethandrolone, acetohexamide or enovid. Toxicol Appl Pharmacol (1969) 0.77
Metabolic fate of methyl n-butyl ketone, methyl isobutyl ketone and their metabolites in mice. Toxicol Lett (1994) 0.77
Effects of acetone and methyl n-butyl ketone on hepatic mixed-function oxidase. Biochem Pharmacol (1989) 0.77
Potentiation of chloroform-induced hepatotoxicity by methyl isobutyl ketone and two metabolites. Can J Physiol Pharmacol (1990) 0.77
Acute alteration of chloroform-induced hepato- and nephrotoxicity by Mirex and Kepone. Toxicol Appl Pharmacol (1979) 0.76
Role of the enterohepatic circulation in the elimination of phenytoin in the rat. Drug Metab Dispos (1978) 0.76
Evidence for the involvement of organelles in the mechanism of ketone-potentiated chloroform-induced hepatotoxicity. Liver (1990) 0.76
Effects of benziodarone on the metabolism and biliary excretion of sulfobromophthalein and related dyes. Proc Soc Exp Biol Med (1969) 0.76
Histomorphometric study of the pulmonary response of guinea pigs to chronic cotton dust inhalation. Toxicol Appl Pharmacol (1986) 0.76
Taurolithocholate-induced intrahepatic cholestasis: potentiation by methyl isobutyl ketone and methyl n-butyl ketone in rats. Toxicol Appl Pharmacol (1985) 0.76
The role of acinar zone 3 hepatocytes in bile formation: influence of bromobenzene treatment on bile formation in the rat. Liver (1990) 0.76
The role of biotransformation-detoxication in acetone-, 2-butanone-, and 2-hexanone-potentiated chloroform-induced hepatotoxicity. Can J Physiol Pharmacol (1987) 0.76
Induction of aryl hydrocarbon hydroxylase in rat lung by marijuana smoke. Toxicol Appl Pharmacol (1975) 0.76
[Liver biopsy in the cow]. Can Vet J (1969) 0.75
Application of linear integration in the morphometric study of mild and severe pulmonary alveolar injury. Exp Mol Pathol (1988) 0.75
Influence of various mixtures of inhaled toluene and xylene on the biological monitoring of exposure to these solvents in rats. Can J Physiol Pharmacol (1992) 0.75
Quantitative aspects in the assessment of liver injury. Environ Health Perspect (1976) 0.75
Morphological aspects of manganese-bilirubin induced cholestasis. Liver (1982) 0.75